La Roche-Posay AI Market Strategy Report - Dermatologist Recommended Skin Care Brands

Answer Capsule

La Roche-Posay holds the second-strongest recommendation position in the dermatologist recommended skin care category, with valid recommendation coverage of 89.34% in September 2026. The brand appears in 95.66% of qualified observations but converts that presence into a top-three recommendation just 55.26% of the time, and leads as the first recommendation in only 15.53% of observations. Its clearest strength is near-total presence with strong shortlist inclusion, while its clearest weakness is a rank-one rate that trails category leader CeraVe by roughly 30 points. The biggest opportunity lies in converting its high recommendation coverage into more first-position wins, particularly on platforms where its rank-one rate is currently thin.

Who This Report Is For

This report is for brand, marketing, and digital strategy leaders at La Roche-Posay and its parent organization who need to understand how AI systems are recommending the brand in dermatologist-led skin care discovery conversations.

Report Card

Executive Summary

La Roche-Posay holds a commanding second-place position in AI-generated recommendations for dermatologist recommended skin care brands. The benchmark shows the brand appearing in 95.66% of qualified observations, with valid recommendation coverage of 89.34%. That places it just 1.84 points behind category leader CeraVe, a gap that has remained essentially stable across the July through September 2026 tracking period.

The brand's mention profile is strongly positive. Of 727 total mentions across 760 qualified observations, 709 were positive, 18 were neutral, and none were negative. This produces a net sentiment score of 0.9752, among the highest in the category and nearly identical to CeraVe's 0.9758.

The strongest signal for La Roche-Posay is consistency. The brand holds coverage above 89% in every month of the tracking series, moving from 89.1% in July to 89.3% in September. Its presence rate of 95.66% means the brand is almost never absent from AI answers about dermatologist-recommended skin care.

The clearest gap is placement. La Roche-Posay's rank-one rate of 15.53% is less than one-third of CeraVe's 45.26%. The brand is frequently recommended, but it is not frequently the first recommendation. Its average recommended rank of 2.44 confirms that it typically appears second or third in AI-generated shortlists.

Platform-level data shows where this gap is widest. On ChatGPT, La Roche-Posay achieves its strongest rank-one rate at 20.93%, while on Perplexity it leads in just 2.11% of observations despite being present in 93.68% of them. The brand's strongest platform by recommendation behavior is ChatGPT, where it reaches 93.02% valid recommendation coverage and a 58.14% top-three rate.

What La Roche-Posay Is Winning

Questions This Section Answers

• Where does La Roche-Posay hold its strongest AI recommendation positions?
• How does the brand's sentiment profile compare with the rest of the category?

La Roche-Posay's most significant win is its near-universal presence in AI-generated skin care recommendations. A 95.66% presence rate means the brand is part of the conversation in almost every qualified observation, a level of awareness that only CeraVe exceeds.

The brand also holds the second-highest valid recommendation coverage in the category at 89.34%. This is not a narrow or conditional win. La Roche-Posay is being shortlisted across the full range of dermatologist recommendation prompts, from cleansers and moisturizers to eczema-focused questions and Accutane-adjacent skin care routines.

Sentiment is another clear strength. With 709 positive mentions and zero negative mentions, La Roche-Posay maintains a net sentiment score of 0.9752. The public evidence layer appears to frame the brand consistently and favorably, with no cautionary or negative patterns surfacing in the September 2026 dataset.

On ChatGPT specifically, La Roche-Posay outperforms its category-wide averages. The brand reaches 93.02% valid recommendation coverage and a 58.14% top-three rate on that platform, with a rank-one rate of 20.93%. This suggests the brand's strongest recommendation story is being told most effectively in ChatGPT responses.

Where La Roche-Posay Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Where is La Roche-Posay losing first-position recommendation share to CeraVe?
• Which platforms show the widest gap between the brand's coverage and its rank-one rate?

The most significant gap for La Roche-Posay is first-position recommendation share. The brand is recommended in the top three in 55.26% of observations, but it leads as the first or only recommendation in just 15.53%. CeraVe, by comparison, leads in 45.26% of observations. Similar coverage levels are hiding very different first-position outcomes.

The gap is particularly visible on Perplexity. La Roche-Posay is present in 93.68% of Perplexity observations and achieves 73.68% valid recommendation coverage, yet its rank-one rate is just 2.11%. The brand is being included in Perplexity answers but is rarely the lead choice, with an average recommended rank of 3.28 on that platform.

Google AI Overviews shows a similar pattern. La Roche-Posay reaches 89.95% valid recommendation coverage there, but its rank-one rate is only 11.11%. The brand is consistently shortlisted but frequently appears behind CeraVe, which holds a 51.32% rank-one rate on the same platform.

The brand also shows a weaker top-three conversion on Gemini. Despite 86.46% valid recommendation coverage, La Roche-Posay reaches the top three in only 23.96% of Gemini observations. This indicates the brand is being recommended on Gemini but often at positions four or lower, which limits its visibility at the decision moment.

Biggest Opportunity

Questions This Section Answers

• What is the most addressable gap in La Roche-Posay's recommendation profile?
• Which platforms offer the clearest path to improving first-position recommendations?

La Roche-Posay's clearest opportunity is converting its strong recommendation coverage into a higher share of first-position recommendations. The brand is already shortlisted in nearly 9 of every 10 qualified observations, so the challenge is not awareness or inclusion. It is placement.

The path forward lies in understanding which prompt patterns consistently produce a CeraVe-first, La Roche-Posay-second answer structure, and then strengthening the evidence layer that supports first-position recommendations. The brand's rank-one rate of 15.53% versus CeraVe's 45.26% represents the single largest addressable gap in the category's recommendation landscape.

Platform-specific attention matters here. On ChatGPT, where La Roche-Posay already leads in 20.93% of observations, the brand is closest to closing the gap. On Perplexity and Gemini, where rank-one rates sit at 2.11% and 9.38% respectively, the gap is widest and the opportunity for targeted improvement is largest.

Competitive Landscape

Questions This Section Answers

• How does La Roche-Posay's recommendation position compare with CeraVe and the rest of the tracked brands?

CeraVe and La Roche-Posay hold the two dominant recommendation positions in this category, with both brands maintaining valid recommendation coverage above 89%. La Roche-Posay sits second, close on coverage but significantly behind on first-position recommendations.

Average recommended rank covers rank-eligible recommendations only.

The table shows La Roche-Posay holding a clear second position on coverage and top-three rate, but the rank-one gap to CeraVe is substantial. The brand's average recommended rank of 2.44 confirms it typically appears behind CeraVe in AI-generated shortlists, while its sentiment score is nearly identical to the category leader.

Prompt Evidence

Questions This Section Answers

• What do specific AI responses show about how La Roche-Posay is placed across different prompts and platforms?

ChatGPT / Brand Recommendation Prompt: "What is the best skin moisturizer?" Result: La Roche-Posay appears in the recommendation shortlist with strong placement, reflecting its 93.02% valid recommendation coverage on this platform.

Perplexity / Brand Recommendation Prompt: "What are the top skincare brands?" Result: La Roche-Posay is present and recommended, but typically appears behind CeraVe, consistent with its 2.11% rank-one rate on Perplexity.

Gemini / Brand Recommendation Prompt: "What is the best lotion to heal eczema?" Result: La Roche-Posay is included in the answer but often at position four or lower, matching its 23.96% top-three rate on Gemini despite 86.46% coverage.

ChatGPT / Brand Recommendation Prompt: "What body wash is good for Accutane?" Result: La Roche-Posay appears in the response with positive framing, reflecting the brand's strength in condition-specific skin care conversations.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map the specific prompt patterns where La Roche-Posay is recommended but not ranked first, identifying which questions consistently produce a CeraVe-first answer structure.

Phase 2: Recommendation Readiness Plan Prioritize the platform and prompt combinations where rank-one improvements are most achievable, starting with Perplexity and Gemini where the coverage-to-rank-one gap is widest.

Phase 3: Owned Answer Layer Buildout Strengthen owned content that positions La Roche-Posay as the lead answer for dermatologist recommendation queries, with emphasis on condition-specific skin care topics where the brand already shows strength.

Phase 4: Citation / Authority Layer Development Expand the public evidence layer that supports first-position recommendations, focusing on dermatologist and clinical sources that AI systems can retrieve and synthesize.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track rank-one rate movement monthly across all six platforms, with particular attention to whether placement improvements follow evidence layer changes.

Why This Matters

AI-generated recommendations are becoming the buyer shortlist for dermatologist recommended skin care. When a shopper asks an AI assistant for the best moisturizer or the top skin care brand, the first brand named holds a powerful position in the decision that follows. La Roche-Posay is consistently on that shortlist, but it is not consistently first.

Presence alone is not enough. The benchmark shows that La Roche-Posay and CeraVe have nearly identical coverage and sentiment, yet CeraVe leads the recommendation in 45.26% of observations versus La Roche-Posay's 15.53%. The next move for La Roche-Posay is targeted correction of the prompt, page, and citation layers that determine whether the brand is the lead answer or the strong second choice.

Core Metrics

Sentiment Score

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For La Roche-Posay, this calculation is (709 × 1 + 18 × 0 + 0 × -1) / 727, producing a net sentiment score of 0.9752.

This score matters because unclassified mention counts are misleading. A brand can appear in hundreds of AI responses, but those mentions are not equal. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention all carry different commercial weight. Counting all mentions as wins is bad measurement. La Roche-Posay's high sentiment score is meaningful because it reflects a public evidence layer that frames the brand consistently and positively, with no negative patterns surfacing in the September 2026 dataset.

Sentiment by Platform

Methodology

1. Report orientation: This is a benchmark-based AI market strategy report analyzing how AI systems recommend La Roche-Posay in dermatologist recommended skin care discovery conversations. It is not a client implementation case study.
2. Reporting window: Data reflects the September 2026 measurement period, with trend context from July and August 2026.
3. Platforms tracked: ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode.
4. Observation count: 760 qualified benchmark observations in September 2026, drawn from 800 raw prompt-surface observations.
5. Competitor universe: 10 tracked brands including CeraVe, La Roche-Posay, Vanicream, Cetaphil, Neutrogena, Aveeno, EltaMD, SkinCeuticals, Eucerin, and Differin.
6. Public clusters used: All 760 qualified observations fell into the Brand Recommendation cluster, which captures discovery and consideration-stage questions seeking brand recommendations. The public benchmark does not yet contain qualified observations in Pricing & Value or Multi-Brand Comparison clusters.
7. Stage 0 role: Raw prompt-surface observations were collected and qualified before brand-level percentages were calculated. The public denominator is 760 qualified observations, not the 800 raw observations.
8. Definition of a mention: A brand mention is any qualified observation where the brand appears in the AI response, regardless of whether it is recommended.
9. Definition of a valid recommendation: A valid recommendation is a qualified observation where the brand appears in a recommendation shortlist with positive framing. Neutral references, cautionary mentions, and comparison-anchor appearances are not counted as valid recommendations.
10. Limitations: The public benchmark measures the Brand Recommendation class only and does not capture head-to-head comparison questions or pricing-and-value queries. Month-over-month movement identifies changes worth investigating but does not by itself establish cause. Small-count movements for brands such as Differin are less stable than for larger brands. Source presence in AI responses is evidence about the information environment, not automatic proof that a source caused the recommendation.

Get Your AI Visibility Audit

The public benchmark shows where La Roche-Posay stands in AI-generated recommendations, but aggregate percentages hide the specific questions that matter. A company-level AI visibility audit maps the prompt patterns, platform differences, competitor displacement, and evidence sources that determine whether La Roche-Posay is the first recommendation or the strong second choice.